Long Day of Spectacular Science for 23,000 Attendees at AACR 2024 Annual Meeting—Sunday Highlights

Highlights of Sunday’s third day of the American Association for Cancer Research (AACR) 2024 Annual Meeting included opening/welcome remarks of AACR CEO Margareet Foti, PhD, and AACR President Philip Greenberg, together with brief remarks by new NCI Director W. Kimryn Rathmell, MD, PhD, and the award of the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine to Pfizer and its Chairman and CEO Albert Bourla, PhD, who were  honored for the company’s long-standing and impressive work in oncology, its deep-rooted commitment to scientific innovation in the development of novel cancer therapeutics, and its steadfast and enduring commitment to the AACR. Bourla gave an acceptance address in which he spoke movingly of the recent colon cancer death of a talented Pfizer woman colleague who he thought might have otherwise become a future CEO of Pfizer. “Time is life and life is time,” Dr. Bourla said, while stating his belief that breathtaking breakthroughs are quite possible now and will constitute quantum steps forward in cancer treatment and cure.  
Login Or Register To Read Full Story